Epigenetic silencing of Na,K-ATPase β₁ subunit gene ATP1B1 by methylation in clear cell renal cell carcinoma

References

• Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18:581 - 92; http://dx.doi.org/10.1093/annonc/mdl498; PMID: 17287242
   PubMed Web of Science ®Google Scholar
• Mancini V, Battaglia M, Ditonno P, Palazzo S, Lastilla G, Montironi R, Bettocchi C, Cavalcanti E, Ranieri E, Selvaggi FP. Current insights in renal cell cancer pathology. Urol Oncol 2008; 26:225 - 38; http://dx.doi.org/10.1016/j.urolonc.2007.05.017; PMID: 18452811
   PubMed Web of Science ®Google Scholar
• Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer 1998; 22:200 - 9; http://dx.doi.org/10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; PMID: 9624531
   PubMed Web of Science ®Google Scholar
• Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, Bentley E, Affara NA, Ferguson-Smith MA, Maher ER. Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 1994; 69:230 - 4; http://dx.doi.org/10.1038/bjc.1994.44; PMID: 8297719
   PubMed Web of Science ®Google Scholar
• Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994; 91:9700 - 4; http://dx.doi.org/10.1073/pnas.91.21.9700; PMID: 7937876
   PubMed Web of Science ®Google Scholar
• Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260:1317 - 20; http://dx.doi.org/10.1126/science.8493574; PMID: 8493574
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271 - 5; http://dx.doi.org/10.1038/20459; PMID: 10353251
   PubMed Web of Science ®Google Scholar
• Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, et al. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res 2008; 14:4726 - 34; http://dx.doi.org/10.1158/1078-0432.CCR-07-4921; PMID: 18676741
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013; 499:43 - 9; http://dx.doi.org/10.1038/nature12222; PMID: 23792563
   PubMed Web of Science ®Google Scholar
• Morris MR, Maher ER. Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics. Genome Med 2010; 2:59; http://dx.doi.org/10.1186/gm180; PMID: 20815920
   PubMedGoogle Scholar
• Avissar-Whiting M, Koestler DC, Houseman EA, Christensen BC, Kelsey KT, Marsit CJ. Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma. Epigenetics 2011; 6:703 - 9; http://dx.doi.org/10.4161/epi.6.6.16158; PMID: 21610323
   PubMed Web of Science ®Google Scholar
• Ricketts CJ, Morris MR, Gentle D, Brown M, Wake N, Woodward ER, Clarke N, Latif F, Maher ER. Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma. Epigenetics 2012; 7:278 - 90; http://dx.doi.org/10.4161/epi.7.3.19103; PMID: 22430804
   PubMed Web of Science ®Google Scholar
• Rajasekaran SA, Barwe SP, Rajasekaran AK. Multiple functions of Na,K-ATPase in epithelial cells. Semin Nephrol 2005; 25:328 - 34; http://dx.doi.org/10.1016/j.semnephrol.2005.03.008; PMID: 16139688
   PubMed Web of Science ®Google Scholar
• Rajasekaran SA, Rajasekaran AK. Na,K-ATPase and epithelial tight junctions. Front Biosci (Landmark Ed) 2009; 14:2130 - 48; http://dx.doi.org/10.2741/3367; PMID: 19273189
   PubMed Web of Science ®Google Scholar
• Vagin O, Dada LA, Tokhtaeva E, Sachs G. The Na-K-ATPase α₁β₁ heterodimer as a cell adhesion molecule in epithelia. Am J Physiol Cell Physiol 2012; 302:C1271 - 81; http://dx.doi.org/10.1152/ajpcell.00456.2011; PMID: 22277755
   PubMed Web of Science ®Google Scholar
• Therien AG, Blostein R. Mechanisms of sodium pump regulation. Am J Physiol Cell Physiol 2000; 279:C541 - 66; PMID: 10942705
   PubMed Web of Science ®Google Scholar
• Rajasekaran SA, Ball WJ Jr., Bander NH, Liu H, Pardee JD, Rajasekaran AK. Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. J Urol 1999; 162:574 - 80; http://dx.doi.org/10.1016/S0022-5347(05)68629-6; PMID: 10411090
   PubMed Web of Science ®Google Scholar
• Rajasekaran SA, Palmer LG, Quan K, Harper JF, Ball WJ Jr., Bander NH, Peralta Soler A, Rajasekaran AK. Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Biol Cell 2001; 12:279 - 95; http://dx.doi.org/10.1091/mbc.12.2.279; PMID: 11179415
   PubMed Web of Science ®Google Scholar
• Inge LJ, Rajasekaran SA, Yoshimoto K, Mischel PS, McBride W, Landaw E, Rajasekaran AK. Evidence for a potential tumor suppressor role for the Na,K-ATPase beta1-subunit. Histol Histopathol 2008; 23:459 - 67; PMID: 18228203
   PubMed Web of Science ®Google Scholar
• Espineda CE, Chang JH, Twiss J, Rajasekaran SA, Rajasekaran AK. Repression of Na,K-ATPase beta1-subunit by the transcription factor snail in carcinoma. Mol Biol Cell 2004; 15:1364 - 73; http://dx.doi.org/10.1091/mbc.E03-09-0646; PMID: 14699059
   PubMed Web of Science ®Google Scholar
• Rajasekaran SA, Huynh TP, Wolle DG, Espineda CE, Inge LJ, Skay A, Lassman C, Nicholas SB, Harper JF, Reeves AE, et al. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol Cancer Ther 2010; 9:1515 - 24; http://dx.doi.org/10.1158/1535-7163.MCT-09-0832; PMID: 20501797
   PubMed Web of Science ®Google Scholar
• Rodrigues M, Balicki D, Newrock KM, Mukherjee BB. Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells. Exp Cell Res 1985; 156:22 - 30; http://dx.doi.org/10.1016/0014-4827(85)90258-7; PMID: 2981174
   PubMed Web of Science ®Google Scholar
• Leone A, Flatow U, King CR, Sandeen MA, Margulies IM, Liotta LA, Steeg PS. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 1991; 65:25 - 35; http://dx.doi.org/10.1016/0092-8674(91)90404-M; PMID: 2013093
   PubMed Web of Science ®Google Scholar
• Weinberg RA. Tumor suppressor genes. Science 1991; 254:1138 - 46; http://dx.doi.org/10.1126/science.1659741; PMID: 1659741
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57 - 70; http://dx.doi.org/10.1016/S0092-8674(00)81683-9; PMID: 10647931
   PubMed Web of Science ®Google Scholar
• Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012; 150:12 - 27; http://dx.doi.org/10.1016/j.cell.2012.06.013; PMID: 22770212
   PubMed Web of Science ®Google Scholar
• Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18:1427 - 31; http://dx.doi.org/10.1093/bioinformatics/18.11.1427; PMID: 12424112
   PubMed Web of Science ®Google Scholar
• Thomas GV, Tran C, Mellinghoff IK, Welsbie DS, Chan E, Fueger B, Czernin J, Sawyers CL. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat Med 2006; 12:122 - 7; http://dx.doi.org/10.1038/nm1337; PMID: 16341243
   PubMed Web of Science ®Google Scholar
• Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293:1089 - 93; http://dx.doi.org/10.1126/science.1063443; PMID: 11498579
   PubMed Web of Science ®Google Scholar
• Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429:457 - 63; http://dx.doi.org/10.1038/nature02625; PMID: 15164071
   PubMed Web of Science ®Google Scholar
• Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13:679 - 92; http://dx.doi.org/10.1038/nrg3270; PMID: 22945394
   PubMed Web of Science ®Google Scholar
• Balch C, Nephew KP. Epigenetic targeting therapies to overcome chemotherapy resistance. Adv Exp Med Biol 2013; 754:285 - 311; http://dx.doi.org/10.1007/978-1-4419-9967-2_14; PMID: 22956507
   PubMed Web of Science ®Google Scholar
• Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821 - 6; http://dx.doi.org/10.1073/pnas.93.18.9821; PMID: 8790415
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178 - 86; http://dx.doi.org/10.1038/ng.298; PMID: 19151715
   PubMed Web of Science ®Google Scholar
• Vanderkraats ND, Hiken JF, Decker KF, Edwards JR. Discovering high-resolution patterns of differential DNA methylation that correlate with gene expression changes. Nucleic Acids Res 2013; 41:6816 - 27; http://dx.doi.org/10.1093/nar/gkt482; PMID: 23748561
   PubMed Web of Science ®Google Scholar
• Evans AJ, Russell RC, Roche O, Burry TN, Fish JE, Chow VW, Kim WY, Saravanan A, Maynard MA, Gervais ML, et al. VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol 2007; 27:157 - 69; http://dx.doi.org/10.1128/MCB.00892-06; PMID: 17060462
   PubMed Web of Science ®Google Scholar
• Mateen S, Raina K, Agarwal C, Chan D, Agarwal R. Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells. J Pharmacol Exp Ther 2013; 345:206 - 14; http://dx.doi.org/10.1124/jpet.113.203471; PMID: 23461975
   PubMed Web of Science ®Google Scholar
• Chik F, Szyf M. Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors. Carcinogenesis 2011; 32:224 - 32; http://dx.doi.org/10.1093/carcin/bgq221; PMID: 20980350
   PubMed Web of Science ®Google Scholar
• Beyer S, Kristensen MM, Jensen KS, Johansen JV, Staller P. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J Biol Chem 2008; 283:36542 - 52; http://dx.doi.org/10.1074/jbc.M804578200; PMID: 18984585
   PubMed Web of Science ®Google Scholar
• Xia X, Lemieux ME, Li W, Carroll JS, Brown M, Liu XS, Kung AL. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci U S A 2009; 106:4260 - 5; http://dx.doi.org/10.1073/pnas.0810067106; PMID: 19255431
   PubMed Web of Science ®Google Scholar
• Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, Zhou M, Rini B, Yan Q, Yang H. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene 2012; 31:776 - 86; http://dx.doi.org/10.1038/onc.2011.266; PMID: 21725364
   PubMed Web of Science ®Google Scholar